GlassScriptPhysician profile
Vlad Detinich
NPI 1801004684
$3,458.97
in general payments reported to CMS, 2019-2025
11 companies · $1,725 in 2025
The $1,725 reported for 2025 was more than what 98% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.79 · 2020: $148 · 2021: $218 · 2022: $66.80 · 2023: $57.23 · 2024: $1,203 · 2025: $1,725.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,033 · Food and Beverage: $878 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,032.81 |
| Food and Beverage | $877.88 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $1,760.54 | 2022-2025 | |
| Ultradent Products INC | $897.01 | 2024 | |
| Zimmer Biomet Holdings, INC. | $253.98 | 2020-2021 | |
| Neoss, INC. | $164.30 | 2024 | Neoss Implant System |
| Dentsply Sirona INC | $142.69 | 2020-2023 | Waveone Gold Conform Fit |
| Voco America INC. | $140.01 | 2024-2025 | Futurabond U, Grandio So Heavy Flow, Admira Fusion X-Tra |
| Dentsply Ih INC. | $25.97 | 2019 | |
| Straumann USA LLC | $25.81 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.13 | 2024 | Exparel |
| Philips North America LLC | $14.82 | 2019 | |
| Kerr Corporation | $11.71 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vlad Detinich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.